LSV Asset Management grew its holdings in Cabot Co. (NYSE:CBT - Free Report) by 40.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 136,600 shares of the specialty chemicals company's stock after acquiring an additional 39,400 shares during the period. LSV Asset Management owned about 0.25% of Cabot worth $12,473,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. R Squared Ltd bought a new stake in shares of Cabot during the fourth quarter valued at approximately $26,000. EverSource Wealth Advisors LLC lifted its stake in Cabot by 37.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock worth $74,000 after purchasing an additional 219 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Cabot by 10.7% during the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock valued at $123,000 after purchasing an additional 130 shares during the last quarter. Manchester Capital Management LLC grew its position in shares of Cabot by 1,685.1% during the fourth quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock valued at $153,000 after purchasing an additional 1,584 shares in the last quarter. Finally, KBC Group NV lifted its position in shares of Cabot by 43.1% in the fourth quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock worth $187,000 after buying an additional 616 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company's stock.
Wall Street Analyst Weigh In
CBT has been the subject of several research analyst reports. Mizuho cut their price target on Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. lowered their price objective on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research report on Friday, February 21st. StockNews.com upgraded shares of Cabot from a "hold" rating to a "buy" rating in a report on Thursday. Finally, UBS Group reduced their price objective on Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research note on Monday, April 7th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat, Cabot has a consensus rating of "Hold" and an average price target of $93.25.
View Our Latest Research Report on CBT
Cabot Trading Up 0.1 %
Shares of NYSE CBT traded up $0.08 during midday trading on Friday, hitting $78.40. The company's stock had a trading volume of 338,411 shares, compared to its average volume of 387,265. The business's 50 day moving average is $82.86 and its two-hundred day moving average is $95.12. Cabot Co. has a 12-month low of $73.63 and a 12-month high of $117.46. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72. The firm has a market cap of $4.25 billion, a P/E ratio of 10.41, a price-to-earnings-growth ratio of 0.74 and a beta of 1.04.
Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping analysts' consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. As a group, equities research analysts expect that Cabot Co. will post 7.57 EPS for the current year.
Cabot Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Further Reading

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.